Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Biological Activity of InfraDure Biopump Secreting Sustained Interferon in HCV Patients

This study has been terminated.
(Company strategic decision)
Information provided by (Responsible Party):
Medgenics Medical Israel Ltd. Identifier:
First received: September 5, 2011
Last updated: September 12, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2014
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)